Quantitative analysis of intestinal flora of Uygur and han ethnic Chinese patients with ulcerative colitis

Gastroenterology Research and Practice

Volumn 2016, Issue , 2016, Pages

  Yao, Ping ^a   Cui, Min ^a   Wang, Haikun ^a   Gao, Hongliang ^a   Wang, Lei ^a   Yang, Tao ^a   Cheng, Yongbo ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

ADULT; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BACTEROIDES; BIFIDOBACTERIUM; CASE CONTROL STUDY; CLOSTRIDIUM; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA EXTRACTION; ETHNIC DIFFERENCE; FAECALIBACTERIUM PRAUSNITZII; FECES ANALYSIS; FEMALE; FLUORESCENCE ANALYSIS; FUSOBACTERIUM; GENE DOSAGE; HAN CHINESE; HUMAN; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POPULATION ABUNDANCE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REMISSION; SPECIES DIFFERENCE; ULCERATIVE COLITIS; UYGUR (PEOPLE);

EID: 84956907410     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2016/9186232     Document Type: Article

References (36)

1. N. A. Molodecky, I. S. Soon, D. M. Rabi, et al., "Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review, " Gastroenterology, vol. 142, no. 1, pp. 46-54, 2012.
2. L. Prideaux, M. A. Kamm, P. P. De Cruz, F. K. L. Chan, and S. C. Ng, "Inflammatory bowel disease in Asia: a systematic review, " Journal of Gastroenterology and Hepatology, vol. 27, no. 8, pp. 1266-1280, 2012.
3. X.-L. Jiang and H.-F. Cui, "An analysis of 10218 ulcerative colitis cases in China, " World Journal of Gastroenterology, vol. 8, no. 1, pp. 158-161, 2002.
4. J. Stephani, K. Radulovic, and J. H. Niess, "Gut microbiota, probiotics and inflammatory bowel disease, " Archivum Immunologiae et Therapiae Experimentalis, vol. 59, no. 3, pp. 161-177, 2011.
5. L. Gentschew and L. R. Ferguson, "Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases, " Molecular Nutrition and Food Research, vol. 56, no. 4, pp. 524-535, 2012.
6. M. W. Khan, A. A. Kale, P. Bere, S. Vajjala, E. Gounaris, and K. C. Pakanati, "Microbes, intestinal inflammation and probiotics, " Expert Review of Gastroenterology and Hepatology, vol. 6, no. 1, pp. 81-94, 2012.
7. T. Gosiewski, M. Strus, K. Fyderek, et al., "Horizontal distribution of the fecal microbiota in adolescents with inflammatory bowel disease, " Journal of Pediatric Gastroenterology and Nutrition, vol. 54, no. 1, pp. 20-27, 2012.
8. M. Bellavia, G. Tomasello, M. Romeo, et al., "Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: a working hypothesis, " Medical Microbiology and Immunology, vol. 202, no. 6, pp. 393-406, 2013.
9. Y. R. Wang, E. V. Loftus Jr., J. R. Cangemi, and M. F. Picco, "Racial/ethnic and regional differences in the prevalence of inflammatory bowel disease in theUnited States, " Digestion, vol. 88, no. 1, pp. 20-25, 2013.
10. A. Arin Letamendia, F. Borda Celaya, M. J. Burusco Paternain, et al., "High incidence rates of inflammatory bowel disease in Navarra (Spain). Results of a prospective, population-based study, " Gastroenterologia y Hepatologia, vol. 31, no. 3, pp. 111-116, 2008.
11. G. Buenavida, A. Casãas, C. Vásquez, et al., "Incidence of inflammatory bowel disease in five geographical areas of Uruguay in the biennial 2007-2008, " Acta Gastroenterologica Latinoamericana, vol. 41, no. 4, pp. 281-287, 2011.
12. F. Gao, X. Liu, and D. Nu, "Comparisons of clinical characteristics in patients with ulcerative colitis between Uygur and Han nationality in Xinjiang, " Zhonghua Xiaohua Neijing Zazhi, vol. 24, pp. 423-426, 2007.
13. F. Scaldaferri, V. Gerardi, L. R. Lopetuso, et al., "Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility, " BioMed Research International, vol. 2013, Article ID 435268, 9 pages, 2013.
14. P. B. Eckburg, E. M. Bik, C. N. Bernstein, et al., "Diversity of the human intestinal microbial flora, " Science, vol. 308, no. 5728, pp. 1635-1638, 2005.
15. R. E. Ley, F. Bäckhed, P. Turnbaugh, C. A. Lozupone, R. D. Knight, and J. I. Gordon, "Obesity alters gut microbial ecology, " Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 31, pp. 11070-11075, 2005.
16. M. E. Sanders, F. Guarner, R. Guerrant, et al., "An update on the use and investigation of probiotics in health and disease, " Gut, vol. 62, no. 5, pp. 787-796, 2013.
17. S. G. Correa, M. Maccioni, V. E. Rivero, P. Iribarren, C. E. Sotomayor, and C. M. Riera, "Cytokines and the immuneneuroendocrine network: what did we learn frominfection and autoimmunity?" Cytokine & Growth Factor Reviews, vol. 18, no. 1-2, pp. 125-134, 2007.
18. T. Sugihara, A. Kobori, H. Imaeda, et al., "The increased mucosalmRNAexpressions of complementC3 and interleukin-in inflammatory bowel disease, " Clinical and Experimental Immunology, vol. 160, no. 3, pp. 386-393, 2010.
19. Inflammatory Bowel Disease Co-operation Group, Chinese Society of Gastroenterology, "Chinese consensus on diagnosis and treatment standard of inflammatory bowel disease, " Chinese Journal of Gastroenterology, vol. 12, no. 8, pp. 488-495, 2007.
20. J. Satsangi, M. S. Silverberg, S. Vermeire, and J.-F. Colombel, "The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications, " Gut, vol. 55, no. 6, pp. 749-753, 2006.
21. T. Rinttilä, A. Kassinen, E. Malinen, L. Krogius, and A. Palva, "Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR, " Journal of AppliedMicrobiology, vol. 97, no. 6, pp. 1166-1177, 2004.
22. J. B. Liu, Y. Wang, and C. H. Wang, "The structure characteristics analysis of Bacteroides and Clostridia in intestinal microflora of normotensive and hypertensive Kazak people in Xinjiang, " Chinese Journal of Microecology, no. 5, pp. 420-422, 2010.
23. H. Kato, A. Yoshida, S. Awano, T. Ansai, and T. Takehara, "Quantitative detection of volatile sulfur compound-producing microorganisms in oral specimens using real-time PCR, " Oral Diseases, vol. 11, supplement 1, pp. 67-71, 2005.
24. R. Verma, A. K. Verma, V. Ahuja, and J. Paul, "Real-timeanalysis ofmucosal flora in patients with inflammatory bowel disease in India, " Journal of Clinical Microbiology, vol. 48, no. 11, pp. 4279-4282, 2010.
25. M. Rajilić-Stojanović, F. Shanahan, F. Guarner, and W. M. de Vos, "Phylogenetic analysis of dysbiosis in ulcerative colitis during remission, " Inflammatory Bowel Diseases, vol. 19, no. 3, pp. 481-488, 2013.
26. W. Hans, J. Schölmerich, V. Gross, and W. Falk, "The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice, " European Journal of Gastroenterology and Hepatology, vol. 12, no. 3, pp. 267-273, 2000.
27. T. P. Prindiville, R. A. Sheikh, S. H. Cohen, Y. J. Tang, M. C. Cantrell, and J. Silva Jr., "Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease, " Emerging Infectious Diseases, vol. 6, no. 2, pp. 171-174, 2000.
28. D. Kelly, J. I. Campbell, T. P. King, et al., "Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclearcytoplasmic shuttling of PPAR-and RelA, " Nature Immunology, vol. 5, no. 1, pp. 104-112, 2004.
29. R. Kumari, V. Ahuja, and J. Paul, "Fluctuations in butyrateproducing bacteria in ulcerative colitis patients of North India, " World Journal of Gastroenterology, vol. 19, no. 22, pp. 3404-3414, 2013.
30. J. J. Kovarik, W. Tillinger, J. Hofer, et al., "Impaired antiinflammatory efficacy of n-butyrate in patients with IBD, " European Journal of Clinical Investigation, vol. 41, no. 3, pp. 291-298, 2011.
31. K. Machiels, M. Joossens, J. Sabino, et al., "A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis, " Gut, vol. 63, no. 8, pp. 1275-1283, 2014.
32. S. Macfarlane, E. Furrie, J. H. Cummings, and G. T. Macfarlane, "Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis, " Clinical Infectious Diseases, vol. 38, no. 12, pp. 1690-1699, 2004.
33. H.-M. Zhao, X.-Y. Huang, Z.-Q. Zuo, et al., "Probiotics increase T regulatory cells and reduce severity of experimental colitis in mice, "World Journal of Gastroenterology, vol. 19, no. 5, pp. 742-749, 2013.
34. S. Tanabe, Y. Kinuta, and Y. Saito, "Bifidobacteriuminfantis suppresses proinflammatory interleukin-17 production in murine splenocytes and dextran sodium sulfate-induced intestinal inflammation, " International Journal ofMolecularMedicine, vol. 22, no. 2, pp. 181-185, 2008.
35. H. Sokol, P. Seksik, L. Rigottier-Gois, et al., "Specificities of the fecal microbiota in inflammatory bowel disease, " Inflammatory Bowel Diseases, vol. 12, no. 2, pp. 106-111, 2006.
36. E. G. Zoetendal, A. vonWright, T. Vilpponen-Salmela, K. Ben-Amor, A. D. L. Akkermans, and W. M. de Vos, "Mucosaassociated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces, " Applied and Environmental Microbiology, vol. 68, no. 7, pp. 3401-3407, 2002.